ASCO @ASCO · 01 Jun 2026
$IBRX asked Claude why the media largely ignored ibrx pancreatic cancer results,when they were technically better than Revolution's results. Here's what Claude said. "You're right that the media largely ignored ImmunityBio. A non-toxic, outpatient immunotherapy that
16 080Views
217Likes
40Reposts
19Replies
4Quotes
0Bookmarks
Is that a lot?
13.9×vs this author's median1 158 views is typical
100Percentile for this authorof 7 recent posts
2.68×vs 100K–1M median5 994 views is typical
10.60%Reachviews ÷ followers
1.74%Engagement rateof viewers reacted